Fritextsökning
Artiklar per år
Innehållstyper
-
Vårdjobben minst attraktiva enligt undersökning
Vårdjobben hamnar längst ner på listan i en undersökning från Manpower Group när tillfrågade svenskar får välja ett bristyrke de skulle kunna tänka att vidareutbilda eller omskola sig till.
-
Confidence in childhood vaccines is in decline worldwide
Since the pandemic, confidence in vaccinating children has plummeted. In a new report, UNICEF urges world leaders to act before the situation worsens. In 52 out of 55 countries surveyed, public perception of the importance of vaccinating children has declined.
-
Uncertainty about the government’s life science work
The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now questions are being raised both about the government’s plans for the office and the Swedish life science strategy.
-
Pfizer’s record year – topped the $100 billion mark
In 2022 Pfizer, as the first pharmaceutical company in history, reached an annual revenue of more than 100 billion dollars, thereby surpassing Johnson & Johnson as the industry’s top selling business.
-
He got inside the head of Sweden’s vaccine hunter
The hunt for the COVID-19 vaccine is the theme of the new book Vaccinjägaren (The Vaccine Hunter). It tells the story of Richard Bergström’s mission as Sweden’s national vaccine coordinator and the scheming that went on behind the scenes in Europe. Author and medical journalist Nils Bergeå co-wrote the book with Richard Bergström.
-
Pfizers rekordår – sprängde 100 miljardersvallen
Pfizer lyckades i fjol, som första läkemedelsbolag i historien, sälja för över 100 miljarder dollar under ett år. Det visar en sammanställning över företagen med de största intäkterna inom läkemedelsindustrin.
-
Life science-profil lämnar vd-jobbet i Umeå
Jennie Ekbeck, vd för Umeå Biotech Incubator (UBI), lämnar sin post efter 11 år. "Jag har nu kommit fram till att det är dags att göra något annat. Vad det är har jag ingen aning om, men framtiden känns väldigt spännande", skriver hon på Linkedin.
-
New diagnostic rules raise concerns
In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagnostics (IVDR). They argue that it may create significant differences between regions, and patients may be affected.
-
Conference on Alzheimer’s reveals several advances in the field
In Gothenburg, Sweden, researchers and pharmaceutical companies from all over the world gathered to discuss one specific issue – neurological diseases. Life Science Sweden has talked to some of those that attended the conference.
-
The impact of the recession on the Swedish medtech sector
We need health care regardless of whether the economy is good or bad, but the current recession also affects the Medtech sector.
-
Den onödiga vården – så ser den ut
Internationell forskning pekar på att vård som ges utan vetenskapligt stöd utgör någonstans mellan 11 och 30 procent av all vård. Det kan bland annat handla om onödiga labbprover och onödiga röntgen- och magnetkameraundersökningar. I en ny avhandling har
-
KI’s new President: “We need to work closer together”
A closer link between research and education and a stronger “we-feeling” are aims that Annika Östman Wernerson sets out to achieve as the new President of Karolinska Institutet. She will not give up her research entirely though. “I think it’s crucial to maintain a close presence in the business,” she says.
-
Positiv jobbprognos inom life science
Trots tuffa tider är sysselsättningsprognoserna inom hälso-, sjukvårds- och life science-branscherna fortsatt optimistiska, visar en ny marknadsbarometer från Manpower.
-
Calliditas aktie rusar efter positiva studieresultat
Nya studiedata för Calliditas njurläkemedel Nefecon fick bolagets aktie att stiga med över 20 procent på måndagsförmiddagen. "Vi tror att datan, baserad på fas III-studiepopulationen, stödjer regulatorisk ansökan om fullständigt godkännande", säger vd:n Renée Aguiar-Lucander.
-
“I am driven by the desire to develop a product that can be sold worldwide”
Ranked number one in the world by the WHO in diarrhoea research and soon in phase III studies for its vaccine candidate – Scandinavian Biopharma is rushing forward in the pursuit of the world’s first ETEC vaccine. Meet the company’s CEO Björn Sjöstrand.
-
Column: ”Cheating with pea flowers and does it matter whether you are right?”
Is it possible to forgive shortcuts or outright cheating in science - if it turns out that the researcher was ultimately right? Anna Törner discuss this topic in a column.
-
Forskningschef på svenskt läkemedelsbolag anhållen för insiderbrott
Två personer har anhållits för grovt insiderbrott efter ett tillslag mot forskningsbolaget Oncopeptides lokaler på onsdagen. En av de anhållna är företagets forskningschef.
-
The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality
Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Experts in the field claim that andrology needs to become a speciality in Sweden to increase awareness and knowledge. But the Swedish National Board of Health and Welfare says that it is not a priority.
-
“An entire industry is about to be wiped out”
According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.
-
How critical are the “Spermageddon” reports? – Researchers call for action
A much talked about meta-study indicates that sperm concentration in men’s seminal fluid has halved in 40 years. Experts in andrology that Life Science Sweden speaks to believe that the results must be taken seriously, and call for action from the Swedish authorities.
-
Column: ”Life as a F1 race”
"The F1 car makes several pit stops during a race and during a lifetime the human being may also have to come in several times for maintenance", Björn Ursing writes in a column.
-
New issue of Life Science Sweden!
The international issue of Life Science Sweden has been sent to press.
-
Editorial: ”AI that both impresses and frightens”
”In the past, I've rarely been particularly impressed by something that was produced by AI. But this is something completely different”, Samuel Lagercrantz writes in an editorial.
-
Hello Jenni Nordborg!
Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.
BREAKING